|
C10ORF119 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.408200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.637010E-04 |
| Normal-vs-Stage2 |
1.002010E-02 |
| Normal-vs-Stage3 |
3.400400E-01 |
| Normal-vs-Stage4 |
5.708600E-01 |
| Stage1-vs-Stage2 |
8.761200E-01 |
| Stage1-vs-Stage3 |
1.700400E-01 |
| Stage1-vs-Stage4 |
3.226800E-01 |
| Stage2-vs-Stage3 |
3.555200E-01 |
| Stage2-vs-Stage4 |
3.737000E-01 |
| Stage3-vs-Stage4 |
9.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.61189999999501E-05 |
| Normal-vs-AfricanAmerican |
8.780100E-02 |
| Normal-vs-Asian |
3.056400E-01 |
| Caucasian-vs-AfricanAmerican |
1.510980E-01 |
| Caucasian-vs-Asian |
9.313400E-01 |
| AfricanAmerican-vs-Asian |
6.821600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58260000004962E-06 |
| Normal-vs-Female |
7.918000E-01 |
| Male-vs-Female |
6.22809999999419E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.122830E-03 |
| Normal-vs-Extreme_Weight |
6.32699999999486E-05 |
| Normal-vs-Obese |
1.014570E-01 |
| Normal-vs-Extreme_Obese |
5.824800E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.922000E-01 |
| Normal_Weight-vs-Obese |
1.303420E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.990400E-01 |
| Extreme_Weight-vs-Obese |
6.566500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.713600E-01 |
| Obese-vs-Extreme_Obese |
7.013800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.316000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.605600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.51253999999268E-05 |
| Normal-vs-Age(81-100Yrs) |
4.47749999999969E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.813600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.445900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.480300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.877970E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.737600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.655600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.388820E-04 |
| Normal-VS-Type2 PRCC |
2.1756000000428E-06 |
| Normal-VS-KIRP CIMP |
3.780800E-03 |
| Normal-VS-Unclassified PRCC |
2.185200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.679440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.72849999991298E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.942220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.88399995183187E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.516300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.979900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.59470000002682E-06 |
| Normal-vs-N1 |
6.911000E-01 |
| Normal-vs-N2 |
3.614000E-01 |
| N0-vs-N1 |
7.994900E-04 |
| N0-vs-N2 |
3.367000E-01 |
| N1-vs-N2 |
5.238800E-01 |
|
|
